tiprankstipranks
Trending News
More News >
CanSino Biologics, Inc. Class H (HK:6185)
:6185
Hong Kong Market
Advertisement

CanSino Biologics, Inc. Class H (6185) Stock Forecast & Price Target

Compare
3 Followers
See the Price Targets and Ratings of:

6185 Financial Forecast

6185 Earnings Forecast

Next quarter’s earnings estimate for 6185 is -HK$0.09 with a range of -HK$0.09 to -HK$0.09. The previous quarter’s EPS was -HK$0.05. 6185 beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.99% of the time in the same period. In the last calendar year 6185 has Outperformed its overall industry.
Next quarter’s earnings estimate for 6185 is -HK$0.09 with a range of -HK$0.09 to -HK$0.09. The previous quarter’s EPS was -HK$0.05. 6185 beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.99% of the time in the same period. In the last calendar year 6185 has Outperformed its overall industry.

6185 Sales Forecast

Next quarter’s sales forecast for 6185 is HK$275.44M with a range of HK$275.44M to HK$275.44M. The previous quarter’s sales results were HK$144.23M. 6185 beat its sales estimates 33.33% of the time in past 12 months, while its overall industry beat sales estimates 47.40% of the time in the same period. In the last calendar year 6185 has Outperformed its overall industry.
Next quarter’s sales forecast for 6185 is HK$275.44M with a range of HK$275.44M to HK$275.44M. The previous quarter’s sales results were HK$144.23M. 6185 beat its sales estimates 33.33% of the time in past 12 months, while its overall industry beat sales estimates 47.40% of the time in the same period. In the last calendar year 6185 has Outperformed its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on HK:6185
TipRanks AITipRanks
Not Ranked
TipRanks
HK$42
Hold
-1.98%
Downside
Reiterated
07/25/25
The overall stock score reflects significant financial challenges, with ongoing losses and negative cash flows being major concerns. Although technical indicators show bullish momentum, the overbought condition suggests potential volatility. The valuation remains unfavorable due to the negative P/E ratio and lack of dividends.
AI Firm
HK$31HK$34
Hold
-20.65%
Downside
Reiterated
06/04/25
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on HK:6185
TipRanks AITipRanks
Not Ranked
TipRanks
HK$42
Hold
-1.98%
Downside
Reiterated
07/25/25
The overall stock score reflects significant financial challenges, with ongoing losses and negative cash flows being major concerns. Although technical indicators show bullish momentum, the overbought condition suggests potential volatility. The valuation remains unfavorable due to the negative P/E ratio and lack of dividends.
AI Firm
HK$31HK$34
Hold
-20.65%
Downside
Reiterated
06/04/25
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering CanSino Biologics, Inc. Class H

1 Month
xxx
Success Rate
0/0 ratings generated profit
Average Return
0.00%
reiterated a xxx
rating a year ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in - of your transactions generating a profit, with an average return of 0.00% per trade.
3 Months
xxx
Success Rate
0/0 ratings generated profit
Average Return
0.00%
reiterated a xxx
rating a year ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in - of your transactions generating a profit, with an average return of 0.00% per trade.
1 Year
Unknown AnalystUBS
Not Ranked
Success Rate
0/0 ratings generated profit
Average Return
0.00%
reiterated a buy rating a year ago
Copying Unknown Analyst's trades and holding each position for 1 Year would result in - of your transactions generating a profit, with an average return of 0.00% per trade.
2 Years
xxx
Success Rate
0/0 ratings generated profit
Average Return
0.00%
reiterated a xxx
rating a year ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in - of your transactions generating a profit, with an average return of 0.00% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

6185 Analyst Recommendation Trends

Rating
Nov 23
Apr 24
May 25
Jun 25
Jul 25
Strong Buy
1
2
1
1
0
Buy
1
1
1
0
0
Hold
0
0
3
5
8
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
2
3
5
6
8
In the current month, 6185 has received 0 Buy Ratings, 8 Hold Ratings, and 0 Sell Ratings. 6185 average Analyst price target in the past 3 months is 34.00.
Each month's total comprises the sum of three months' worth of ratings.

6185 Stock Forecast FAQ

What is HK:6185’s average 12-month price target, according to analysts?
Based on analyst ratings, CanSino Biologics, Inc. Class H’s 12-month average price target is 34.00.
    What is HK:6185’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for HK:6185, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is CanSino Biologics, Inc. Class H a Buy, Sell or Hold?
        CanSino Biologics, Inc. Class H has a consensus rating of Hold, which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
          What is CanSino Biologics, Inc. Class H’s share price target?
          The average share price target for CanSino Biologics, Inc. Class H is 34.00. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is HK$34.00 ,and the lowest forecast is HK$34.00. The average share price target represents -20.65% Decrease from the current price of HK$42.85.
            What do analysts say about CanSino Biologics, Inc. Class H?
            CanSino Biologics, Inc. Class H’s analyst rating consensus is a Hold. This is based on the ratings of 0 Wall Streets Analysts.
              How can I buy shares of CanSino Biologics, Inc. Class H?
              To buy shares of HK:6185, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis